Viking Global Investors
Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.
Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.
View Older Stories View More Recent Stories
-
ID.me Raises $100 Million in Funding at $1.5 Billion Valuation to Build the Identity Layer of the Internet
-
Allonnia Announces Evok Innovations as Strategic Investor, Raises Additional $20M to Develop and Scale Transformational Waste Management Technologies
-
Druva Appoints Robert Brower as Leader for Global Partners and Alliances
-
Form SC 13G Orion Acquisition Corp. Filed by: VIKING GLOBAL INVESTORS LP
-
Form D/A Viking Global Equities
-
Form D/A Viking Global Equities
-
Form D/A Viking Global Equities
-
Amunix Raises $117 Million Series B Financing to Fund its Oncology Pipeline
-
Amunix Raises $117 Million Series B Financing to Fund its Oncology Pipeline
-
Druva Teams with Leidos on NASA NEST Contract
-
Druva Recognized for Excellence in Customer Success as Most Awarded Cloud Vendor at 2021 Stevie® Awards
-
Impossible Foods Launches 2021 Internship Program
-
Druva Appoints Scott Morris as Vice President of APJ Sales Organization
-
Form 13F-HR VIKING GLOBAL INVESTORS For: Dec 31
-
Form SC 13G/A Athira Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Chewy, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A PMV Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A AbCellera Biologics Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Vertex, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G Pharvaris N.V. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Canada Goose Holdings Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Inhibrx, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A aTYR PHARMA INC Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Change Healthcare Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A GoHealth, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Adaptive Biotechnologies Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Zentalis Pharmaceuticals Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G/A Nuance Communications, Filed by: VIKING GLOBAL INVESTORS LP
-
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines
-
Sema4 to Combine with SPAC, CM Life Sciences (CMLF)
-
Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth
-
Day One Announces $130 Million Series B Financing to Accelerate New Targeted Cancer Treatments for Children
-
Impossible Foods Cuts Suggested Grocery Store Prices 20%
-
Analysis: To the brink and back on GameStop - Wall Street vs Reddit
-
Viking Global Hedge Fund Down Single Digits in Market Tumult - Bloomberg
-
Impossible Foods Earns Top Score in Human Rights Campaign’s 2021 Corporate Equality Index
-
Pandemic Pushes 89 Percent of Indian IT Leaders to Protect Organizational Data from Ransomware According to New Survey
-
Top hedge funds earn $63.5 billion in 2020, highest in a decade: LCH data
-
Christiana Figueres Joins Impossible Foods’ Board of Directors
-
Druva Receives Cyber Catalyst Designation for Outstanding Product Security and Ability to Combat Ransomware
-
Form D/A Viking Global Opportunit
-
Form D/A Viking Global Opportunit
-
Affinivax Announces $226 Million Series C Financing to Advance Its Pipeline of Novel MAPS™ Vaccines Targeting Infectious Diseases
-
With Increasing Economies of Scale, Impossible Foods Delivers Double-Digit Price Reductions for the Second Time in One Year
-
Color announces $167 million in Series D financing to help build public health infrastructure across the U.S.
-
Form SC 13G/A AbCellera Biologics Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Impossible Foods Donates Its Millionth Burger and Doubles Down on Social Good For 2021
-
Form SC 13G AbCellera Biologics Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13G 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
